Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BLVD Centers Co. stock logo
CXV
BLVD Centers
C$0.07
+∞
C$0.07
C$0.05
C$0.18
C$16.28MN/A1.10 million shs1.59 million shs
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$32.21
-0.9%
$36.05
$26.06
$46.40
$277.75M1.5713,275 shs14,276 shs
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BLVD Centers Co. stock logo
CXV
BLVD Centers
0.00%0.00%0.00%0.00%0.00%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-0.31%+2.85%-10.34%-7.17%-24.05%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BLVD Centers Co. stock logo
CXV
BLVD Centers
N/AN/AN/AN/AN/AN/AN/AN/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
1.1547 of 5 stars
3.52.00.00.01.01.70.0

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BLVD Centers Co. stock logo
CXV
BLVD Centers
N/AN/AN/AN/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
3.00
Buy$44.0036.60% Upside

Current Analyst Ratings

Latest SMTI, CXV, and CMBN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/27/2024
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$49.00 ➝ $44.00
2/6/2024
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$49.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BLVD Centers Co. stock logo
CXV
BLVD Centers
N/AN/AN/AN/AN/AN/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$64.99M4.27N/AN/A$5.22 per share6.17

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BLVD Centers Co. stock logo
CXV
BLVD Centers
N/AN/A0.00N/AN/AN/AN/AN/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$4.30M-$0.52N/AN/A-6.62%-11.12%-7.11%5/20/2024 (Estimated)

Latest SMTI, CXV, and CMBN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/25/2024Q4 2023
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
N/A-$0.03-$0.03-$0.03N/A$17.69 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BLVD Centers Co. stock logo
CXV
BLVD Centers
N/AN/AN/AN/AN/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BLVD Centers Co. stock logo
CXV
BLVD Centers
N/AN/AN/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
0.20
1.38
1.04

Ownership

Institutional Ownership

CompanyInstitutional Ownership
BLVD Centers Co. stock logo
CXV
BLVD Centers
N/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
8.10%

Insider Ownership

CompanyInsider Ownership
BLVD Centers Co. stock logo
CXV
BLVD Centers
N/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
55.20%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BLVD Centers Co. stock logo
CXV
BLVD Centers
N/A232.62 millionN/ANot Optionable
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
1078.62 million3.86 millionNot Optionable

SMTI, CXV, and CMBN Headlines

SourceHeadline
Envoy Medical (NASDAQ:COCH) vs. Sanara MedTech (NASDAQ:SMTI) Critical ReviewEnvoy Medical (NASDAQ:COCH) vs. Sanara MedTech (NASDAQ:SMTI) Critical Review
americanbankingnews.com - April 24 at 2:04 AM
Shandong Weigao Group Medical Polymer (OTCMKTS:SHWGF) & Sanara MedTech (NASDAQ:SMTI) Head-To-Head ReviewShandong Weigao Group Medical Polymer (OTCMKTS:SHWGF) & Sanara MedTech (NASDAQ:SMTI) Head-To-Head Review
americanbankingnews.com - April 21 at 1:44 AM
Sanara MedTech Inc. Announces $55 Million Debt FacilitySanara MedTech Inc. Announces $55 Million Debt Facility
globenewswire.com - April 18 at 9:15 AM
Sanara MedTech (NASDAQ:SMTI)  Shares Down 0.2% Sanara MedTech (NASDAQ:SMTI) Shares Down 0.2%
marketbeat.com - April 18 at 12:40 AM
Sanara Medtech Inc (SMTI)Sanara Medtech Inc (SMTI)
investing.com - April 11 at 7:36 AM
Sanara MedTech Names Jake Waldrop COO, Effective April 15; Stock Up In Pre-marketSanara MedTech Names Jake Waldrop COO, Effective April 15; Stock Up In Pre-market
markets.businessinsider.com - April 5 at 10:14 AM
Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy OfficerSanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer
globenewswire.com - April 5 at 9:00 AM
Sanara MedTech Inc. (NASDAQ:SMTI) Q4 2023 Earnings Call TranscriptSanara MedTech Inc. (NASDAQ:SMTI) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 29 at 9:57 AM
Sanara MedTech Inc. (SMTI) Q4 2023 Earnings Call TranscriptSanara MedTech Inc. (SMTI) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 28 at 1:54 PM
Cantor Fitzgerald Trims Sanara MedTech (NASDAQ:SMTI) Target Price to $44.00Cantor Fitzgerald Trims Sanara MedTech (NASDAQ:SMTI) Target Price to $44.00
marketbeat.com - March 27 at 10:15 AM
SMTI Stock Earnings: Sanara MedTech Beats EPS, Beats Revenue for Q4 2023SMTI Stock Earnings: Sanara MedTech Beats EPS, Beats Revenue for Q4 2023
investorplace.com - March 25 at 9:39 PM
Sanara MedTech Inc (SMTI) Reports Strong Sales Growth and Reduced Net Loss for Full Year 2023Sanara MedTech Inc (SMTI) Reports Strong Sales Growth and Reduced Net Loss for Full Year 2023
finance.yahoo.com - March 25 at 7:09 PM
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 ResultsSanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results
globenewswire.com - March 25 at 4:05 PM
Sanara MedTechs Earnings: A PreviewSanara MedTech's Earnings: A Preview
benzinga.com - March 22 at 4:38 PM
Investors in Sanara MedTech (NASDAQ:SMTI) have seen fantastic returns of 541% over the past five yearsInvestors in Sanara MedTech (NASDAQ:SMTI) have seen fantastic returns of 541% over the past five years
finance.yahoo.com - March 13 at 12:55 PM
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call DatesSanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates
globenewswire.com - March 13 at 9:15 AM
Cyient partners with MassMedic to accelerate MedTech innovationCyient partners with MassMedic to accelerate MedTech innovation
pharmabiz.com - March 6 at 6:08 PM
CGI Cellerate RX, LLCs Net WorthCGI Cellerate RX, LLC's Net Worth
benzinga.com - March 6 at 6:08 PM
Sanara MedTech Stock (NASDAQ:SMTI), Analyst Ratings, Price Targets, PredictionsSanara MedTech Stock (NASDAQ:SMTI), Analyst Ratings, Price Targets, Predictions
benzinga.com - February 23 at 2:58 AM
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023
globenewswire.com - February 22 at 9:15 AM
Sanara MedTech Inc. (NASDAQ:SMTI) About To Shift From Loss To ProfitSanara MedTech Inc. (NASDAQ:SMTI) About To Shift From Loss To Profit
finance.yahoo.com - January 5 at 8:20 AM
Sanara MedTech announces exclusive license agreement for patented collagen peptidesSanara MedTech announces exclusive license agreement for patented collagen peptides
msn.com - January 3 at 1:43 PM
Sanara MedTech Inks Exclusive License Agreement With Tufts UniversitySanara MedTech Inks Exclusive License Agreement With Tufts University
markets.businessinsider.com - January 3 at 1:43 PM
Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen PeptidesSanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides
finance.yahoo.com - January 3 at 1:43 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

BLVD Centers logo

BLVD Centers

CVE:CXV
BLVD Centers Corporation provides detoxification and outpatient rehabilitation services. It operates rehabilitation centers under the BLVD Centers brand name in Los Angeles, Orange County, Corona, and San Diego, California; and Portland, Oregon. The company was formerly known as Convalo Health International, Corp. and changed its name to BLVD Centers Corporation in June 2017. BLVD Centers Corporation was incorporated in 2013 and is headquartered in Los Angeles, California.
Sanara MedTech logo

Sanara MedTech

NASDAQ:SMTI
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.